Efficacy and safety of calcium and vitamin D3 in treatment of steroid osteoporosis in asthmatic patients

A. Yemelyanov, S. Shevelev, B. Murzin, S. Shubin (Saint-Petersburg, Russia)

Source: Annual Congress 2001 - Asthma
Session: Asthma
Session type: Thematic Poster Session
Number: 441
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yemelyanov, S. Shevelev, B. Murzin, S. Shubin (Saint-Petersburg, Russia). Efficacy and safety of calcium and vitamin D3 in treatment of steroid osteoporosis in asthmatic patients. Eur Respir J 2001; 16: Suppl. 31, 441

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
1,25-dihydroxyvitamin D3 effect on corticosteroid sensitivity in obese asthmatic patients before and after bariatric surgery
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020


Efficacy of long-lasting magnesium supplementation in asthmatic children
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


Can vitamin D3 supplementation reduce the time to severe asthma exacerbations in children with asthma?
Source: Breathe, 17 (3) 210071; 10.1183/20734735.0071-2021
Year: 2021



Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010

One year vitamin D and parathyroid hormone influence in patients with OSAS and CPAP treatment
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018


Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012

Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012

Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


Role of vitamin D in asthma severity and control in children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012


Osteoporosis in patients with long-term inhaled corticosteroids treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 613s
Year: 2007

Lack of association between inhaled corticosteroids and bone density in postmenopausal women
Source: Eur Respir J 2001; 18: Suppl. 33, 442s
Year: 2001

Decreasing dose protocol for omalizumab treatment in oral corticosteroid allergic asthma patients
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011


The association between inhaled corticosteroid and osteoporosis and fracture
Source: Eur Respir J, 57 (6) 2100216; 10.1183/13993003.00216-2021
Year: 2021



Clinical impact of vitamin D deficiency on Tunisian asthmatics
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Efficacy of antioxidant supplementation diet in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

The efficacy of steroid with pentoxifylline in steroid resistant sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006

Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Effect of vitamin D levels on asthma control in adults
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019



Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010